You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Colorcon
Moodys
Express Scripts
AstraZeneca

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Tivantinib


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Tivantinib?

Tivantinib is an investigational drug.

There have been 27 clinical trials for Tivantinib. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2010.

The most common disease conditions in clinical trials are Carcinoma, Lung Neoplasms, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are National Cancer Institute (NCI), Daiichi Sankyo Inc., and ArQule.

There are twenty US patents protecting this investigational drug and one hundred and forty-one international patents.

Recent Clinical Trials for Tivantinib
TitleSponsorPhase
TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)Istituto Oncologico Veneto IRCCSPhase 2
Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic ImpairmentMedpace, Inc.Phase 1
Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic ImpairmentDaiichi Sankyo Inc.Phase 1

See all Tivantinib clinical trials

Clinical Trial Summary for Tivantinib

Top disease conditions for Tivantinib
Top clinical trial sponsors for Tivantinib

See all Tivantinib clinical trials

US Patents for Tivantinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tivantinib   Start Trial Combination therapy using c-Met inhibitor and IGF-1R inhibitor for c-Met inhibitor resistant cancers SAMSUNG ELECTRONICS CO., LTD. (Suwon-si, KR) YONSEI UNIVERSITY, UNIVERSITY-INDUSTRY FOUNDATION (UIF) (Seoul, KR)   Start Trial
Tivantinib   Start Trial Method for predicting efficacy of c-Met inhibitor SAMSUNG ELECTRONICS CO., LTD. (Suwon-si, KR)   Start Trial
Tivantinib   Start Trial Compositions and methods for treatment of cancer ArQule, Inc. (Woburn, MA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Baxter
Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.